357 related articles for article (PubMed ID: 26936181)
1. [The Washington summit: orange light for genome editing?].
Jordan B
Med Sci (Paris); 2016 Feb; 32(2):217-20. PubMed ID: 26936181
[TBL] [Abstract][Full Text] [Related]
2. Genome Editing, Ethics, and Politics.
Gabel I; Moreno J
AMA J Ethics; 2019 Dec; 21(12):E1105-1110. PubMed ID: 31876477
[TBL] [Abstract][Full Text] [Related]
3. Legal issues regarding gene editing at the beginning of life: an EU perspective.
De Miguel Beriain I
Regen Med; 2017 Sep; 12(6):669-679. PubMed ID: 28976851
[TBL] [Abstract][Full Text] [Related]
4. [CRISPR-Cas9, germinal cells and human embryo].
Jouannet P
Biol Aujourdhui; 2017; 211(3):207-213. PubMed ID: 29412130
[TBL] [Abstract][Full Text] [Related]
5. What would responsible remedial human germline editing look like?
Adashi EY; Cohen IG
Nat Biotechnol; 2020 Apr; 38(4):398-400. PubMed ID: 32214241
[No Abstract] [Full Text] [Related]
6. The ethics of creating genetically modified children using genome editing.
Ishii T
Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):418-423. PubMed ID: 28885275
[TBL] [Abstract][Full Text] [Related]
7. Proceedings of the International Summit on Human Gene Editing: a global discussion-Washington, D.C., December 1-3, 2015.
LaBarbera AR
J Assist Reprod Genet; 2016 Sep; 33(9):1123-7. PubMed ID: 27278445
[TBL] [Abstract][Full Text] [Related]
8. After the Storm - A Responsible Path for Genome Editing.
Daley GQ; Lovell-Badge R; Steffann J
N Engl J Med; 2019 Mar; 380(10):897-899. PubMed ID: 30649993
[No Abstract] [Full Text] [Related]
9. An ethical pathway for gene editing.
Savulescu J; Singer P
Bioethics; 2019 Feb; 33(2):221-222. PubMed ID: 30695116
[No Abstract] [Full Text] [Related]
10. CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations.
Memi F; Ntokou A; Papangeli I
Semin Perinatol; 2018 Dec; 42(8):487-500. PubMed ID: 30482590
[TBL] [Abstract][Full Text] [Related]
11. Gene-edited babies: What went wrong and what could go wrong.
Wang H; Yang H
PLoS Biol; 2019 Apr; 17(4):e3000224. PubMed ID: 31039144
[TBL] [Abstract][Full Text] [Related]
12. The tsunami named CRISPR/Cas9.
Chneiweiss H
Rev Neurol (Paris); 2018; 174(7-8):487-488. PubMed ID: 29779853
[No Abstract] [Full Text] [Related]
13. The morality and ethics governing CRISPR-Cas9 patents in China.
Peng Y
Nat Biotechnol; 2016 Jun; 34(6):616-8. PubMed ID: 27281418
[No Abstract] [Full Text] [Related]
14. What Is Prudent Governance of Human Genome Editing?
Schweikart SJ
AMA J Ethics; 2019 Dec; 21(12):E1042-1048. PubMed ID: 31876467
[TBL] [Abstract][Full Text] [Related]
15. Why Include the Public in Genome Editing Governance Deliberation?
Blasimme A
AMA J Ethics; 2019 Dec; 21(12):E1065-1070. PubMed ID: 31876471
[TBL] [Abstract][Full Text] [Related]
16. Commissions, Consensus, and CRISPR.
Barrangou R
CRISPR J; 2020 Oct; 3(5):316-317. PubMed ID: 33095046
[No Abstract] [Full Text] [Related]
17. Science and Bioethics of CRISPR-Cas9 Gene Editing: An Analysis Towards Separating Facts and Fiction.
Cribbs AP; Perera SMW
Yale J Biol Med; 2017 Dec; 90(4):625-634. PubMed ID: 29259526
[TBL] [Abstract][Full Text] [Related]
18. Rogues and Regulation of Germline Editing.
Charo RA
N Engl J Med; 2019 Mar; 380(10):976-980. PubMed ID: 30650001
[No Abstract] [Full Text] [Related]
19. Societal and Ethical Impacts of Germline Genome Editing: How Can We Secure Human Rights?
Halpern J; O'Hara SE; Doxzen KW; Witkowsky LB; Owen AL
CRISPR J; 2019 Oct; 2(5):293-298. PubMed ID: 31599687
[TBL] [Abstract][Full Text] [Related]
20. Ethics of Human Genome Editing.
Coller BS
Annu Rev Med; 2019 Jan; 70():289-305. PubMed ID: 30691366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
